MicroRNAs contribute to the chemoresistance of cisplatin in tongue squamous cell carcinoma lines

Yu, Zhi-wei; Zhong, Lai-ping; Ji, Tong; Zhang, Ping; Chen, Wan-tao; Zhang, Chen-ping

doi:10.1016/j.oraloncology.2010.02.002

« Previous Next »Oral Oncology
Volume 46, Issue 4 , Pages 317-322, April 2010

MicroRNAs contribute to the chemoresistance of cisplatin in tongue squamous cell carcinoma lines

Zhi-wei Yu
Lai-ping Zhong
- Corresponding authors. Address: Department of Oral and Maxillofacial Surgery, Ninth People’s Hospital, School of Stomatology, Shanghai Jiao Tong University School of Medicine, Shanghai Key Laboratory of Stomatology and Shanghai Research Institute of Stomatology, No. 639 Zhizaoju Road, Shanghai 200011, China. Tel.: +86 21 23271699 5154; fax: +86 21 63136856 (L.-p. Zhong); tel.: +86 21 23271699 5161; fax: +86 21 63136856 (C.-p. Zhang).
Tong Ji
Ping Zhang
Wan-tao Chen
Chen-ping Zhang
- Corresponding authors. Address: Department of Oral and Maxillofacial Surgery, Ninth People’s Hospital, School of Stomatology, Shanghai Jiao Tong University School of Medicine, Shanghai Key Laboratory of Stomatology and Shanghai Research Institute of Stomatology, No. 639 Zhizaoju Road, Shanghai 200011, China. Tel.: +86 21 23271699 5154; fax: +86 21 63136856 (L.-p. Zhong); tel.: +86 21 23271699 5161; fax: +86 21 63136856 (C.-p. Zhang).

Department of Oral and Maxillofacial Surgery, Ninth People’s Hospital, School of Stomatology, Shanghai Jiao Tong University School of Medicine, Shanghai Key Laboratory of Stomatology and Shanghai Research Institute of Stomatology, Shanghai 200011, China

Received 4 January 2010; received in revised form 31 January 2010; accepted 1 February 2010. published online 11 March 2010.

Summary

MicroRNAs (miRNAs) are small non-coding RNAs that function as negative regulators of gene expression. They are strongly implicated in human cancers, including oral squamous cell carcinoma (OSCC). Evidence for the involvement of miRNAs as important regulators of chemosensitivity and chemoresistance in OSCC is not well understood. In this study, miRNA microarray was firstly used to compare the differential miRNAs levels between the cisplatin-sensitive tongue squamous cell carcinoma line (Tca8113) and its cisplatin-resistant subline (Tca/cisplatin). Three miRNAs of miR-21, -214, and -23a were validated by miRNAs real-time PCR, and intervened by anti-miRNA oligonucleotides (miR-214 and -23a) and pre-miRNA plasmid transfection (miR-21). Further relationship between miR-23a and DNA topoisomerase II beta (TOP2B) on the chemoresistance against cisplatin was studied. There were 19 out of 480 differential miRNAs between the Tca8113 and Tca/cisplatin cells. miR-214 and -23a were found increased as with chemoresistance against cisplatin in the Tca/cisplatin cells while miR-21 was found decreased as with chemosensitivity for cisplatin in the Tca/cisplatin cells. Intervention of these three miRNAs could decrease the chemoresistance against cisplatin in Tca/cisplatin cells. Transfection of anti-miR-23a into the Tca/cisplatin cells could increase the TOP2B protein expression. Our results suggest the existence of differential miRNAs with chemosensitivity and chemoresistance between the cisplatin-sensitive and resistant tongue squamous cell carcinoma lines. miR-21 serves as a chemosensitive miRNA, while miR-214 and -23a serve as chemoresistant miRNAs in the tongue squamous cell carcinoma lines. miR-23a is an up-stream regulator of TOP2B to realize the chemoresistance of cisplatin.

Keywords: MicroRNA, Tongue squamous cell carcinoma, Chemoresistance, Chemosensitivity, Cisplatin, Oral cancer